Alex Tabarrok
-
Bartley J. Madden Chair in Economics, Mercatus Center at George Mason UniversityProfessor of Economics, George Mason University
Alex Tabarrok is the Bartley J. Madden Chair in Economics at the Mercatus Center at George Mason University and a professor of economics at George Mason University. He has written extensively about health care policy, patent-system reform, the effectiveness of bounty hunters, how judicial elections bias judges, and how local poverty rates impact trial decisions by juries. He has also written about methods for increasing the supply of human organs for transplant, the regulation of pharmaceuticals by the FDA, and voting systems. During the pandemic, Tabarrok was an advisor to the US government on using incentives to accelerate vaccine production. Tabarrok's papers have appeared in Science, The Journal of Human Resources, The Journal of Law and Economics, the Journal of Health Economics, The Proceedings of the National Academy of Sciences (PNAS) and many other journals.
Tabarrok is the coauthor, with Mercatus colleague Tyler Cowen, of the popular economics blog Marginal Revolution and cofounder of the online educational platform Marginal Revolution University. He is the coauthor of Modern Principles of Economics and his popular articles have appeared in the New York Times, the Washington Post, the Wall Street Journal, and many other prestigious publications. Tabarrok earned his PhD in Economics from George Mason University and is an alum of the Mercatus PhD Fellowship.
For a current list of publications, see Alex's Google Scholar page and his personal website.
Latest Work
-
- | Podcast Appearance Podcast Appearance
Britain’s equal pay madness | CapX
-
- | Expert Commentary Expert Commentary
The US Misses Both Paths to Faster Trials | Real Clear Health
-
-
-
-
- | Expert Commentary Expert Commentary
A Slogan For An Age Of Idiocracy | RealClearMarkets
-
- | Expert Commentary Expert Commentary
The 21st Century ROAD to Housing Act | Marginal Revolution
-
- | Expert Commentary Expert Commentary
RFK Jr.’s FDA Is Killing New Drug Development | RealClearMarkets
-
- | Mercatus Podcasts Mercatus Podcasts
- | The Marginal Revolution Podcast The Marginal Revolution Podcast
America's Debt: Crisis or Calm?
Can America afford $30 trillion in debt—or is the real question whether it wants to?
-
- | Mercatus Podcasts Mercatus Podcasts
- | The Marginal Revolution Podcast The Marginal Revolution Podcast
The Return of Tariffs
Unpacking incidence, retaliation, and the return of protectionism
-
- | Academic & Student Programs Academic & Student Programs
- | Journal Articles Journal Articles
Measuring Criminal Spillovers: Evidence from Three Strikes
-
- | Academic & Student Programs Academic & Student Programs
- | Journal Articles Journal Articles
From off-label prescribing towards a new FDA
-
- | Academic & Student Programs Academic & Student Programs
- | Journal Articles Journal Articles
Do Off-Label Drug Practices Argue against FDA Efficacy Requirements?
A Critical Analysis of Physicians' Argumentation for Initial Efficacy Requirements -
- | Academic & Student Programs Academic & Student Programs
- | Journal Articles Journal Articles
Book Chapter: Medical drugs and devices
-
- | Academic & Student Programs Academic & Student Programs
- | Journal Articles Journal Articles
The Rise, Fall, and Rise Again of Privateers
-
- | Academic & Student Programs Academic & Student Programs
- | Journal Articles Journal Articles
Does Three Strikes Deter?
A Non-Parametric Estimation
-
- | India Political Economy Program India Political Economy Program
- | Policy Briefs Policy Briefs
Pandemic Policy in Developing Countries: Recommendations for India
-
- | Policy Briefs Policy Briefs
Grand Innovation Prizes to Address Pandemics: A Primer
-
- | Podcast Appearance Podcast Appearance
Britain’s equal pay madness | CapX
-
-
-
- | Mercatus Podcasts Mercatus Podcasts
- | The Marginal Revolution Podcast The Marginal Revolution Podcast
America's Debt: Crisis or Calm?
Can America afford $30 trillion in debt—or is the real question whether it wants to?
-
- | Mercatus Podcasts Mercatus Podcasts
- | The Marginal Revolution Podcast The Marginal Revolution Podcast
The Return of Tariffs
Unpacking incidence, retaliation, and the return of protectionism
-
- | Mercatus Podcasts Mercatus Podcasts
- | The Marginal Revolution Podcast The Marginal Revolution Podcast
Compensating Differentials and Selective Incentives
Why do all good things come together in some jobs but not others?
-
- | Mercatus Podcasts Mercatus Podcasts
- | The Marginal Revolution Podcast The Marginal Revolution Podcast
The Baumol Effect
Why Services Get More Expensive (And Why That Is Actually Good)
-
- | Mercatus Podcasts Mercatus Podcasts
- | The Marginal Revolution Podcast The Marginal Revolution Podcast
Favorite Models: Spence on Monopolies, Harberger on Incidence, Solow on Growth
Why the Best Models Endure Even When They’re Wrong
-
- | Mercatus Podcasts Mercatus Podcasts
- | The Marginal Revolution Podcast The Marginal Revolution Podcast
In Praise of Commercial Culture
Revisiting Tyler’s 1998 book: what it got right, what’s changed, and whether markets still make art better
-
- | Radio Appearance Radio Appearance
Why Are US Drug Prices So High? | The Human Action Podcast
-
- | Federal Testimonies Federal Testimonies
Vaccinations and the Economic Recovery in 2021
Joint Economic Committee
-
- | Expert Commentary Expert Commentary
The US Misses Both Paths to Faster Trials | Real Clear Health
-
-
- | Expert Commentary Expert Commentary
A Slogan For An Age Of Idiocracy | RealClearMarkets
-
- | Expert Commentary Expert Commentary
The 21st Century ROAD to Housing Act | Marginal Revolution
-
- | Expert Commentary Expert Commentary
RFK Jr.’s FDA Is Killing New Drug Development | RealClearMarkets
-
- | India Political Economy Program India Political Economy Program
- | Expert Commentary Expert Commentary
India's Talent Trap: Rent-seeking and exams in India's public sector exams | Business 360
-
-
- | Regulation Regulation
- | Expert Commentary Expert Commentary
‘The Licensing Racket’ Review: There’s a Board for That | The Wall Street Journal
-
- | Expert Commentary Expert Commentary
We’re Looking at Inequality All Wrong – Just Ask the NFL | Barron's
-
-
- | Podcast Appearance Podcast Appearance
Britain’s equal pay madness | CapX
-
- | Expert Commentary Expert Commentary
The US Misses Both Paths to Faster Trials | Real Clear Health
-
-
-
-
- | Expert Commentary Expert Commentary
A Slogan For An Age Of Idiocracy | RealClearMarkets
-
- | Expert Commentary Expert Commentary
The 21st Century ROAD to Housing Act | Marginal Revolution
-
- | Expert Commentary Expert Commentary
RFK Jr.’s FDA Is Killing New Drug Development | RealClearMarkets
-
- | Mercatus Podcasts Mercatus Podcasts
- | The Marginal Revolution Podcast The Marginal Revolution Podcast
America's Debt: Crisis or Calm?
Can America afford $30 trillion in debt—or is the real question whether it wants to?
-
- | Mercatus Podcasts Mercatus Podcasts
- | The Marginal Revolution Podcast The Marginal Revolution Podcast
The Return of Tariffs
Unpacking incidence, retaliation, and the return of protectionism
-
- | Academic & Student Programs Academic & Student Programs
- | Journal Articles Journal Articles
Measuring Criminal Spillovers: Evidence from Three Strikes
-
- | Academic & Student Programs Academic & Student Programs
- | Journal Articles Journal Articles
From off-label prescribing towards a new FDA
-
- | Academic & Student Programs Academic & Student Programs
- | Journal Articles Journal Articles
Do Off-Label Drug Practices Argue against FDA Efficacy Requirements?
A Critical Analysis of Physicians' Argumentation for Initial Efficacy Requirements -
- | Academic & Student Programs Academic & Student Programs
- | Journal Articles Journal Articles
Book Chapter: Medical drugs and devices
-
- | Academic & Student Programs Academic & Student Programs
- | Journal Articles Journal Articles
The Rise, Fall, and Rise Again of Privateers
-
- | Academic & Student Programs Academic & Student Programs
- | Journal Articles Journal Articles
Does Three Strikes Deter?
A Non-Parametric Estimation
-
- | India Political Economy Program India Political Economy Program
- | Policy Briefs Policy Briefs
Pandemic Policy in Developing Countries: Recommendations for India
-
- | Policy Briefs Policy Briefs
Grand Innovation Prizes to Address Pandemics: A Primer
-
- | Podcast Appearance Podcast Appearance
Britain’s equal pay madness | CapX
-
-
-
- | Mercatus Podcasts Mercatus Podcasts
- | The Marginal Revolution Podcast The Marginal Revolution Podcast
America's Debt: Crisis or Calm?
Can America afford $30 trillion in debt—or is the real question whether it wants to?
-
- | Mercatus Podcasts Mercatus Podcasts
- | The Marginal Revolution Podcast The Marginal Revolution Podcast
The Return of Tariffs
Unpacking incidence, retaliation, and the return of protectionism
-
- | Mercatus Podcasts Mercatus Podcasts
- | The Marginal Revolution Podcast The Marginal Revolution Podcast
Compensating Differentials and Selective Incentives
Why do all good things come together in some jobs but not others?
-
- | Mercatus Podcasts Mercatus Podcasts
- | The Marginal Revolution Podcast The Marginal Revolution Podcast
The Baumol Effect
Why Services Get More Expensive (And Why That Is Actually Good)
-
- | Mercatus Podcasts Mercatus Podcasts
- | The Marginal Revolution Podcast The Marginal Revolution Podcast
Favorite Models: Spence on Monopolies, Harberger on Incidence, Solow on Growth
Why the Best Models Endure Even When They’re Wrong
-
- | Mercatus Podcasts Mercatus Podcasts
- | The Marginal Revolution Podcast The Marginal Revolution Podcast
In Praise of Commercial Culture
Revisiting Tyler’s 1998 book: what it got right, what’s changed, and whether markets still make art better
-
- | Radio Appearance Radio Appearance
Why Are US Drug Prices So High? | The Human Action Podcast
-
- | Federal Testimonies Federal Testimonies
Vaccinations and the Economic Recovery in 2021
Joint Economic Committee
-
- | Expert Commentary Expert Commentary
The US Misses Both Paths to Faster Trials | Real Clear Health
-
-
- | Expert Commentary Expert Commentary
A Slogan For An Age Of Idiocracy | RealClearMarkets
-
- | Expert Commentary Expert Commentary
The 21st Century ROAD to Housing Act | Marginal Revolution
-
- | Expert Commentary Expert Commentary
RFK Jr.’s FDA Is Killing New Drug Development | RealClearMarkets
-
- | India Political Economy Program India Political Economy Program
- | Expert Commentary Expert Commentary
India's Talent Trap: Rent-seeking and exams in India's public sector exams | Business 360
-
-
- | Regulation Regulation
- | Expert Commentary Expert Commentary
‘The Licensing Racket’ Review: There’s a Board for That | The Wall Street Journal
-
- | Expert Commentary Expert Commentary
We’re Looking at Inequality All Wrong – Just Ask the NFL | Barron's
-